Loading
IARC estimates 16,995 new cancer cases and 10,041 cancer deaths in Bolivia in 2024; the commonest new cancers are cervix uteri, prostate and breast. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 1,745 | 29.2 | Cervical cancer |
| Prostate | 1,586 | 33.9 | Prostate cancer |
| Breast | 1,266 | 20.7 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Stomach | 986 | 9.1 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 955 | 8.9 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Liver and intrahepatic bile ducts | 880 | 8.2 | Hepatocellular carcinoma |
| Leukaemia | 722 | 5.9 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Gallbladder | 716 | 6.7 | Gallbladder cancer |
| Colorectum | 678 | 6.4 | Colorectal cancer |
| Thyroid | 553 | 4.9 | Thyroid cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 1,014 | 17.2 | Cervical cancer |
| Trachea, bronchus and lung | 875 | 8.2 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Liver and intrahepatic bile ducts | 803 | 7.4 | Hepatocellular carcinoma |
| Stomach | 799 | 7.5 | Gastric & gastro-oesophageal junction cancer |
| Prostate | 597 | 12.6 | Prostate cancer |
| Gallbladder | 574 | 5.5 | Gallbladder cancer |
| Leukaemia | 461 | 3.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Breast | 416 | 6.9 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 386 | 3.7 | Colorectal cancer |
| Pancreas | 323 | 3.1 | Pancreatic ductal adenocarcinoma |
No trial record in OnCo lists a site in Bolivia. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Bolivia.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Bolivia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Bolivia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.